Legal Challenges of the Covid-19 Vaccination Program: A Comparative Discourse between Malaysia and Australia

  • Mastika Nasrun Faculty of Law, Universiti Teknologi MARA, Selangor, Malaysia
  • Norazlina Abdul Aziz Faculty of Law, Universiti Teknologi MARA, Selangor, Malaysia
  • Nurasma Yahaya Faculty of Law, Universiti Teknologi MARA, Selangor, Malaysia
  • Sarah Munirah Abdullah Faculty of Law, Universiti Teknologi MARA, Selangor, Malaysia
Keywords: vaccine, COVID-19, Malaysia, drug control authority, law


During the spread of the COVID-19 pandemic, many health-related industries were alarmed and pressured to innovate solutional vaccines to reduce the effect of the COVID-19 pandemic. Extra effort and lab activities had taken place in several jurisdictions to respond to the increased demand for the COVID-19 vaccine. With these attempts, various vaccines were created and entered the market. All countries designed their own COVID-19 programme in the route to combat the viruses. These countries showed their willingness to invest to secure access to vaccines. In parallel to this development, the vaccination program is bombarded with several issues such as safety assurance, equal access to the vaccine, and protests by the anti-vaccine group. The inability to address these issues will jeopardise the success of building herd immunity which is the core in eradicating COVID-19 cases. Thus, this study explored and analysed the issues and challenges to have an effective vaccination program in a battle against the spread of the COVID-19 virus. It is a comparative study between Malaysia and Australia that includes safety measures, anti-vaccine groups and access to vaccines. This study adopts a qualitative method utilising the doctrinal study on the legal framework that describes the scope and limitation of power accorded to the Drug Control Authority of the selected jurisdictions. The research activities also include semi-structured interviews with relevant authorities using online interviews. The data are analysed using content and thematic analysis. Findings to this study may assist in identifying the loopholes within the administrative control on the vaccination program adopted by Malaysia.


Download data is not yet available.


Abdul Aziz, N. (2017). The Need for Legal and Administrative Framework for Halal Pharmaceutical in Malaysia.

Armiento, R., Hoq, M., Kua, E., Crawford, N., Perrett, K. P., Elia, S., & Danchin, M. (2020). Impact of Australian mandatory 'No Jab, No Pay and 'No Jab, No Play' immunisation policies on immunisation services, parental attitudes to vaccination, and vaccine uptake, in a tertiary pediatric hospital, the Royal Children's Hospital, Melbourne. Vaccine, 38(33), 5231–5240.

Association of State and Territorial Health Officials. (2020). COVID-19 Vaccine Approval Process. Department of Health Therapeutic Goods Administration.

Australian Government. (n.d.). Australia COVID-19 Vaccination Policy.

Australian Government. (2020). Australia’s Covid-19 Vaccine and Treatment.

Berita Harian. (, June). Kerajaan kaji tindakan undang-undang kepada golongan antivaksin. BH Online.

Bernama. (2021a). AstraZeneca COVID-19 Vaccine Safe for Use in Malaysia - Dr. Adham.

Bernama. (2021b). Isu pembekalan vaksin COVID-19 syarikat Pfizer tak jejas bekalan untuk Malaysia - Khairy. Astroawani.

Blyth, C. C., Flanagan, K. L., Gibbs, R. A., Crawford, N. W., & Cheng, A. C. (2021). Key steps in Our Journey to a COVID-19 Vaccine Program. Medical Journal of Australia, 214(6), 249-251.e1.

Borriello, A., Master, D., Pellegrini, A., & Rose, J. M. (2021). Preferences for a COVID-19 Vaccine in Australia. Vaccine, 39(3), 473–479.

Clinical Trials Arena. (2020). Australia's Queensland University begins the Covid-19 vaccine trial. Clinical Trials Arena.

Davis, J., Ferreira, D., Denholm, J. T., & Tong, S. Y. (2020). Clinical trials for the prevention and treatment of coronavirus disease 2019 (COVID-19): The current state of play | The Medical Journal of Australia. The Medical Journal of Australia.

Department of Health. (2021a). COVID-19 vaccines | Australian Government Department of Health.

Department of Health. (2021b). How COVID-19 vaccines are tested and approved | Australian Government Department of Health.

Australian Covid-19 Vaccination Policy, (2020).

Department of Health Australian Government. (2021). Australia's s Vaccine Agreements.

Department of Health Therapeutic Good Administration. (2021). Vaccines overview 14.

Deplanque, D., & Launay, O. (2021). Efficacy of COVID-19 vaccines: From clinical trials to real life. Therapies, 76(4), 277–283.

Emily, H. (2021). Vaccine Doses to Enhance Rollout of Life -.

Gelling, P. (2021). Australia imposes penalties on anti-vaxxers. The World.

Joslyn Panting, A., Mohd Zin, Z., Jaafar, N., Perialathan, K., Shafizal Sheikh Ilman, S., Ridwan Zakaria, M., & Author, C. (2018). Potential Factors Contributing to Vaccine Hesitancy among Parents in Malaysia: An Overview. International Journal of Health Sciences & Research (Www.Ijhsr.Org), 8(7), 360.

Kashte, S., Gulbake, A., El-Amin, S. F., & Gupta, A. (2021). COVID-19 Vaccines: Rapid Development, Implications, Challenges, and Future Prospects. Human Cell, 34(3), 711–733.

Kaur, R. J., Dutta, S., Bhardwaj, P., Charan, J., Dhingra, S., Mitra, P., Singh, K., Yadav, D., Sharma, P., & Misra, S. (2021). Adverse Events Reported From COVID-19 Vaccine Trials: A Systematic Review. Indian Journal of Clinical Biochemistry.

Khoo, Y. S. K., Ghani, A. A., Navamukundan, A. A., Jahis, R., & Gamil, A. (2020). Unique product quality considerations in vaccine development, registration, and new program implementation in Malaysia. Human Vaccines and Immunotherapeutics, 16(3), 530–538.

Kumari, B. S., G.Sai, H., M.V., Nagabhushanam D.Nagarjuna, R., & Brahmaiah, B. (2016). Current Regulatory Requirements for Registration of Medicines, Compilation, and Submission of Dossier in Australian Therapeutic Goods Administration. International Journal of Advanced Scientific and Technical Research, 6(6), 144–157.

Kuok, Y. C., & Wong, T. (2021). Guide on Covid-19 Vaccination: Regulatory Issues. Rajah & Tann Asia.

Lisa, L. M., & David Kelen, G. (2021). Is the COVID-19 Vaccine Safe?

Loomes, P. (2021). Coronavirus vaccine : What we misunderstand about anti-vaxxers. News.Com.Au.

MacIntyre, C. R., Costantino, V., & Trent, M. (2021). Modeling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia. Vaccine, XXXX, 0–7.

Mukherjee, R. (2020). Global efforts on vaccines for COVID-19 : Since, sooner or later, we all will catch the coronavirus. Journal of Biosciences, 45, 1–10.

National Centre for Immunisation Research and Surveillance. (2020). Phases of clinical trials | NCIRS.

Panting, A., Mohd Zin, Z., Jaafar, N., Perialathan, K., Sheikh Ilman, S. S., & Zakaria, M. R. (2020). Potential Factors Contributing to Vaccine Hesitancy among Parents in Malaysia : An Overview. International Journal of Health Science and Research, 8(July 2018), 360–365.

Pharmaceuticals Export Promotion Council of India. (2018). Regulatory & Market Profile of Australia. In Pharmexcil.

Pharmout. (2016). White Paper: How to List or Register a Medicine in Australia (pp. 1–17).

Ramli, M. A., Suet Yan, D. S., & Lim, M. H. (2020). Combating Covid-19: Legal Requirement and Procedures for the Importation of Vaccine into Malaysia. Azmi & Associates.

Reset Australia Research Memo. (2021). Anti-vaccination & Vaccine Hesitant Narratives Intensify in Australian Facebook Groups.

Rumetta, J., Abdul-Hadi, H., & Lee, Y. K. (2020). A Qualitative Study on Parents’ Reasons and Recommendations for Childhood Vaccination Refusal in Malaysia. Journal of Infection and Public Health, 13(2), 199–203.

Seale, H., Heywood, A. E., Leask, J., Sheel, M., Durrheim, D. N., Bolsewicz, K., & Kaur, R. (2021). Examining Australian Public Perceptions and Behaviors towards a Future COVID-19 Vaccine. BMC Infectious Diseases, 21(1), 1–9.

Sharun, K., & Dhama, K. (2021). COVID-19 Vaccine Diplomacy and Equitable Access to Vaccines Amid Ongoing Pandemic. Archives of Medical Research, XXXX, 19–21.

Silva, J., Bratberg, J., & Lemay, V. (2021). COVID-19 and Influenza Vaccine Hesitancy among College Students. Journal of the American Pharmacists Association.

The Secretariat of the Special Committee for Ensuring Access to Covid-19 Supply (JKJAV). (2021). National Covid-19 Immunisation Programme (Issue February).

The Special Committee for Ensuring Access to COVID-19 Vaccine. (2020). AstraZeneca COVID-19 Vaccine (AZD1222).

Therapeutic Goods Administration. (2020). What are “therapeutic goods”? Department of Health Therapeutic Goods Administration.

Therapeutic Goods Administration. (2021). COVID-19 vaccine advertising and import compliance. Department of Health.

Therapeutic Goods Administration (TGA). (2021). Advisory Committee on Vaccines (ACV). Australian Government Department of Health Therapeutic Goods Administration.

Vaughan, G. (1995). The Australian Drug Regulatory System. Australian Prescriber, NPS Medicinewise, 3 July.

Wan Abhar, W. N. A. (2021). Safety Updates on COVID-19 Vaccine (Comirnaty®). National Pharmaceutical Regulatory Agency (NPRA).

Wan Taib, W. R., Mohd Yusoff, N. A., Raja Hussin, T. M. A., & Ahmad, A. (2017). Issues in Vaccine Hesitancy in Malaysia. J. of Biomed. & Clin. Sci, 2(June), 42–46.

Wilson, C. (2021a). Anti-vaxxers are flooding Parliament with petitions about vaccines. MSN News.

Wilson, C. (2021b). Australians are embracing anti-vaccine Facebook groups filled with conspiracy theories and lies. MSN News.

Wong, Y. J., & Lee, S. W. H. (2021). COVID-19 : A call for awareness or mandatory vaccination even in pandemics ? Journal of Global Health, 11, 2019–2021.

World Health Organisation. (2021). Statement for healthcare professionals: How COVID-19 vaccines are regulated for safety and effectiveness: Joint Statement from the International Coalition of Medicines Regulatory Authorities and World Health Organisation. 1–11.

Yeoh, L., & Jua Wen, P. (2021). Mandatory Covid-19 Vaccination To Reach Herd Immunity in Malaysia. Lexology.
How to Cite
Nasrun, M., Abdul Aziz, N., Yahaya, N. and Abdullah, S. M. (2021) “Legal Challenges of the Covid-19 Vaccination Program: A Comparative Discourse between Malaysia and Australia”, Malaysian Journal of Social Sciences and Humanities (MJSSH), 6(10), pp. 319 - 333. doi: 10.47405/mjssh.v6i10.1078.